Ftse Mib
33.778,74
-1,51%
DAX
17.932,17
-1,10%
S&P 500
5.063,39
-1,03%
NASDAQ Composite
15.778,96
-1,28%
Bitcoin
60.057,39
-5,93%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Amicus Therapeutics Inc (FOLD) Amicus Therapeutics Inc (FOLD) Notizie

Amicus Therapeutics Inc

FOLD
10,05
-0,20 (-1,95%)
Ultimo aggiornamento: 21:21:03
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
20/3/202412:00GLOBEAmicus Therapeutics Issues 2024 Environmental, Social, and..
11/3/202422:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202423:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202423:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202423:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202422:30EDGAR2Form 144 - Report of proposed sale of securities
04/3/202423:35EDGAR2Form 144 - Report of proposed sale of securities
01/3/202422:39EDGAR2Form 144 - Report of proposed sale of securities
01/3/202422:33EDGAR2Form 144 - Report of proposed sale of securities
01/3/202413:00GLOBEAmicus Therapeutics to Present at Upcoming Investor..
28/2/202413:02EDGAR2Form 8-K - Current report
28/2/202413:00GLOBEAmicus Therapeutics Announces Full-Year 2023 Financial..
20/2/202423:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/2/202423:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/2/202423:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202422:22EDGAR2Form 144 - Report of proposed sale of securities
15/2/202422:19EDGAR2Form 144 - Report of proposed sale of securities
15/2/202422:19EDGAR2Form 144 - Report of proposed sale of securities
15/2/202413:00GLOBEAmicus Therapeutics to Announce Full Year 2023 Financial..
14/2/202422:38EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202422:26EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202415:22EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/2/202422:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/2/202413:00GLOBEAmicus Therapeutics Receives the 2024 New Treatment Award..
06/2/202422:15EDGAR2Form 144 - Report of proposed sale of securities
06/2/202401:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202401:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202422:45EDGAR2Form 144 - Report of proposed sale of securities
01/2/202422:44EDGAR2Form 144 - Report of proposed sale of securities
01/2/202413:00GLOBEAmicus Therapeutics Announces Presentations and Posters at..
26/1/202417:49EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
24/1/202423:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/1/202422:18EDGAR2Form 144 - Report of proposed sale of securities
18/1/202423:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/1/202422:25EDGAR2Form 144 - Report of proposed sale of securities
12/1/202400:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/1/202400:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/1/202400:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/1/202400:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/1/202400:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202422:06EDGAR2Form 144 - Report of proposed sale of securities
10/1/202400:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202400:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/1/202422:27EDGAR2Form 144 - Report of proposed sale of securities
09/1/202422:27EDGAR2Form 144 - Report of proposed sale of securities
08/1/202422:12EDGAR2Form 144 - Report of proposed sale of securities
08/1/202422:11EDGAR2Form 144 - Report of proposed sale of securities
08/1/202413:01EDGAR2Form 8-K - Current report
07/1/202422:00GLOBEAmicus Therapeutics Reports Preliminary 2023 Revenue and..
06/1/202400:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: 10,17 Min: 10,03 Max: 10,23
Chiusura: 10,25

La tua Cronologia

NASDAQ
FOLD
Amicus Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network